PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma
Clinical trial NCT02492815 · COMPLETED
Trial details
- NCT number
- NCT02492815
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-10-31
- Primary completion
- 2016-04-30
- Enrollment
- 1773
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.